跳至主要内容
临床试验/JPRN-UMIN000013482
JPRN-UMIN000013482已完成未知

A Phase II Study of Olanzapine, Palonosetron and Dexamethasone for nausea and vomiting induced by the highly emetic chemotherapy including Cisplatin - Olanzapine + Palonosetron + Dexamethasone therapy for nausea and vomiting induced by highly emetic chemotherapy

Aichi Cancer Center Hospital0 个研究点目标入组 41 人开始时间: 2014年3月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) known prior severe hypersensitivity (2) patients who do not have enough whole body state to the antineoplastic agents treatment (3) known symptomatic brain metastasis (4) patients who has a convulsive disorders that need anticonvulsants therapy (5) patients with a symptom who has ascites or pleural effusion that need puncture (6) pregnant, breastfeeding or expecting woman (7) patients enforced radiotherapy at the bottom of diaphragm on the period between 6 days before and 6 days after of the date of first therapy (8) patients who take a medicine regularly ,for example , 5HT3 receptor antagonists, corticosteroids, antidopamine agonists, phenothiazine tranquilizers,antihistamine drugs, benzodiazepine,agents, etc (9) patients who can not hospitalize during 120 hours from cisplatin administration (10) judged by the investigator to be inappropriate for this study

研究者

发起方
Aichi Cancer Center Hospital

相似试验